Aquagenic pruritus is referred to a rare dermatological disorder that causes intense itching or a prickling feeling when exposed to water at any temperature. It causes severe itching, stinging, tingling, or burning feelings after coming into touch with water, although there are no apparent changes on the skin. This condition has no recognized etiology but familial occurrences have been reported. Aquagenic pruritis can be a sign of various illnesses, such as polycythemia vera. The symptoms and a clinical examination are used to make a diagnosis. Treatment is symptomatic which include skin lotions, antihistamines, phototherapy, adjusting the pH of the water, and various drugs have been attempted.
This report contains market size and forecasts of Aquagenic Pruritus Treatment in Global, including the following market information:
Global Aquagenic Pruritus Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Aquagenic Pruritus Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aquagenic Pruritus Treatment include Pfizer, Merck, Lupin, Eli Lilly, Abbott, F. Hoffmann-La Roche, GlaxoSmithKline, Bayer AG and Boehringer Ingelheim International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aquagenic Pruritus Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aquagenic Pruritus Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Aquagenic Pruritus Treatment Market Segment Percentages, by Type, 2021 (%)
Medication
Phototherapies
Transcutaneous Electrical Nerve Stimulation (TENS)
Others
Global Aquagenic Pruritus Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Aquagenic Pruritus Treatment Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Global Aquagenic Pruritus Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Aquagenic Pruritus Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aquagenic Pruritus Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Aquagenic Pruritus Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
Lupin
Eli Lilly
Abbott
F. Hoffmann-La Roche
GlaxoSmithKline
Bayer AG
Boehringer Ingelheim International
AstraZeneca
Johnson & Johnson
Sanofi
Novartis AG
Aurobindo Pharma
Mylan N.V.
Dr. Reddy’s Laboratories
BASF SE
Allergan
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
AbbVie
Takeda Pharmaceutical
Sumitomo Dainippon Pharma
Cipla
Bristol-Myers Squibb